Home/Filings/4/0001104659-23-126900
4//SEC Filing

Lam Thomas S. 4

Accession 0001104659-23-126900

CIK 0001083446other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:35 PM ET

Size

12.1 KB

Accession

0001104659-23-126900

Insider Transaction Report

Form 4
Period: 2023-12-15
Transactions
  • Award

    Common Stock

    2023-12-15+30,000321,855 total
  • Award

    Common Stock

    2023-12-15+30,000351,855 total
  • Award

    Common Stock

    2023-12-15+30,000381,855 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,107,474
  • Common Stock

    (indirect: By Allied Physicians of California, a Professional Medical Corporation)
    7,132,698
Footnotes (5)
  • [F1]These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F2]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.
  • [F3]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall vest in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors.
  • [F4]Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of a pre-established performance goal, the shares of restricted stock shall, based on the date the performance goal is achieved, vest either (i) in four equal annual installments, beginning on a date during the first quarter of 2025 to be determined by the compensation committee of the Issuer's board of directors or (ii) three annual installments of 15,000, 7,500 and 7,500, respectively, beginning on a date during the first quarter of 2026 to be determined by the compensation committee.
  • [F5]Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals.

Issuer

Apollo Medical Holdings, Inc.

CIK 0001083446

Entity typeother

Related Parties

1
  • filerCIK 0001664499

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:35 PM ET
Size
12.1 KB